Nephrocare Health IPO
Historical offer record. This offer is closed for applications. Prices and subscriptions describe the past offer; GMP observations are unofficial past records, not current quotes or listing predictions.
Data provider: FinAPI. This is a third-party summary, not an official prospectus. Read our data limitations and editorial policy.
No GMP observations are available for this historical offer record. No premium or listing-gain estimate is shown.
Price band
₹438 – ₹460
Lot size
32 shares
Offer application amount
₹14,720
Issue size
₹871.05 Cr
Historical offer amount for 1 lot at the upper issue price. Confirm the lot size and application terms in the issuer prospectus.
Reported IPO schedule
| Open date | 10 Dec 2025 |
| Close date | 12 Dec 2025 |
| Allotment finalisation | 15 Dec 2025 |
| Refund initiation | 16 Dec 2025 |
| Shares credited to demat | 16 Dec 2025 |
| Reported listing date | 17 Dec 2025 |
Issue size
About Nephrocare Health
Nephrocare Health Services Ltd. has been in the business of offering end-to-end dialysis care since 2010, with a large network of clinics across India and international markets. Diagnosis, haemodialysis, home and mobile dialysis, and wellness programs are among the services provided by Nephrocare, which also has its own pharmacy.
Company summary supplied by FinAPI. Read the prospectus for the issuer's disclosures and audited financials.
Use of proceeds
| Capital expenditure by the Company for opening new dialysis clinics in India and | ₹129.11 |
| Pre-payment, or scheduled repayment, in full or part, of certain borrowings availed by the Company | ₹136 |
| General corporate purposes | ₹- |
Offer documents and primary references
Read the issuer's offer document and any corrigenda for the full disclosures. A third-party details page is a summary; SEBI filing access does not imply an endorsement of the offer or this website.
IPO information is sourced from public feeds and shown for general information only. It is not a recommendation to apply for this or any IPO. IPOs are equity investments and carry market risk; listing gains are not guaranteed and SME IPOs are especially volatile. Grey Market Premium (GMP) is unofficial and not endorsed by SEBI or the exchanges. Equity IPOs are applied for through a demat and trading account, not through mutual fund distribution services. Read the RHP and consult a SEBI-registered investment adviser before investing.